Xenetic Biosciences Inc.
XBIO | NASDAQ
$2.49
-$0.50 (-16.72%)
Sep 22, 2026, 1:50 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.26M | 3.19M | 2.98M | 2.86M | 2.45M | 2.58M | 2.5M | 2.52M | 2.52M | 2.44M | 2.54M | 2.35M | 2.16M | 1.92M | 1.71M | 1.55M | 1.49M | 1.36M | 1.16M | 979.42K | 746.09K | 571.41K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.96K | 7.96K | 7.96K | 17.24K | 9.28K | 9.28K | 9.28K | n/a | n/a | n/a |
Gross Profit | 2.6M | 3.19M | 2.98M | 2.86M | 2.45M | 2.58M | 2.5M | 2.52M | 2.52M | 2.44M | 2.54M | 2.35M | 2.15M | 1.92M | 1.7M | 1.54M | 1.48M | 1.35M | 1.15M | 979.42K | 746.09K | 571.41K |
Operating Income | -2.64M | -2.39M | -2.83M | -3.31M | -3.27M | -3.88M | -4.2M | -4.36M | -5.01M | -4.87M | -4.52M | -4.82M | -4.52M | -6.01M | -6.72M | -7.03M | -7.56M | -6M | -5.75M | -5.09M | -14.22M | -14.08M |
Interest Income | 120.33K | 154.56K | 148K | 156.07K | 186.59K | 215.8K | 249.86K | 281.75K | 312.25K | 374.91K | 355.76K | 351.81K | 305.49K | 195.35K | 167.15K | 116.79K | 99.34K | 104.11K | 100.47K | 92.15K | 89.06K | 96.95K |
Pretax Income | -2.48M | -2.23M | -2.68M | -3.16M | -3.08M | -3.67M | -3.96M | -4.08M | -4.7M | -4.47M | -4.13M | -4.45M | -4.19M | -5.82M | -6.55M | -6.91M | -7.46M | -5.89M | -5.65M | -5M | -14.13M | -13.98M |
Net Income | -2.48M | -2.23M | -2.68M | -3.16M | -3.08M | -3.67M | -3.96M | -4.08M | -4.7M | -4.47M | -4.13M | -4.45M | -4.19M | -5.82M | -6.55M | -6.91M | -7.46M | -5.89M | -5.65M | -5M | -11.21M | -11.06M |
Selling & General & Admin | 3.16M | 2.74M | 2.75M | 2.84M | 2.77M | 3.24M | 3.42M | 3.66M | 3.65M | 3.47M | 3.56M | 3.47M | 3.58M | 3.66M | 3.65M | 3.76M | 3.85M | 3.71M | 3.73M | 3.65M | 3.51M | 3.4M |
Research & Development | 2.74M | 2.85M | 3.07M | 3.33M | 2.95M | 3.22M | 3.29M | 3.22M | 3.87M | 3.84M | 3.49M | 4.2M | 3.58M | 4.75M | 5.26M | 4.81M | 5.19M | 3.64M | 3.16M | 2.43M | 2.22M | 2M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -1 | -1 | -1 | -1 | n/a | -488.75K | -488.75K | -488.75K | -488.75K | 1 | 1 | n/a | n/a | n/a | 9.24M | 9.24M |
Operating Expenses | 5.9M | 5.58M | 5.81M | 6.17M | 5.71M | 6.46M | 6.7M | 6.88M | 7.53M | 7.31M | 7.06M | 7.18M | 6.67M | 7.93M | 8.42M | 8.56M | 9.04M | 7.35M | 6.9M | 6.07M | 14.97M | 14.65M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.9M | 5.58M | 5.81M | 6.17M | 5.71M | 6.46M | 6.7M | 6.88M | 7.53M | 7.31M | 7.06M | 7.18M | 6.68M | 7.94M | 8.42M | 8.58M | 9.04M | 7.36M | 6.91M | 6.07M | 14.97M | 14.65M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.92M | -2.92M |
Shares Outstanding (Basic) | 2.29M | 2.29M | 2.29M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.53M | 1.52M | 1.52M | 1.52M | 1.27M | 1.27M | 1.27M | 1.02M | 1.02M | 851.29K | 874.63K |
Shares Outstanding (Diluted) | 2.29M | 2.29M | 2.29M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M | 1.53M | 1.52M | 1.52M | 1.52M | 1.27M | 1.27M | 1.27M | 1.02M | 1.02M | 874.67K | 874.63K |
EPS (Basic) | -1.19 | -1.23 | -1.62 | -2.05 | -2 | -2.38 | -2.57 | -2.65 | -3.06 | -2.92 | -2.67 | -2.82 | -2.73 | -4.12 | -4.80 | -5.69 | -6.42 | -5.64 | -5.97 | -5.76 | -16.44 | -16.66 |
EPS (Diluted) | -1.19 | -1.23 | -1.62 | -2.05 | -2 | -2.38 | -2.57 | -2.65 | -3.06 | -2.92 | -2.67 | -2.82 | -2.73 | -4.12 | -4.80 | -5.69 | -6.42 | -5.61 | -5.94 | -5.73 | -16.41 | -16.66 |
EBITDA | -2.52M | -2.23M | -2.68M | -3.16M | -3.08M | -3.67M | -3.96M | -4.08M | -4.69M | -4.46M | -4.11M | -4.4M | -4.15M | -5.77M | -6.51M | -6.88M | -7.42M | -5.86M | -5.63M | -5.01M | -4.93M | -4.8M |
EBIT | -1.55M | -2.23M | -2.68M | -3.16M | -3.08M | -3.67M | -3.96M | -4.08M | -4.7M | -4.47M | -4.13M | -4.45M | -4.19M | -5.82M | -6.55M | -6.91M | -7.46M | -5.89M | -5.67M | -5.05M | -4.96M | -4.83M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.64K | 10.5K | 23.42K | 41.62K | 41.93K | 47.84K | 44.4K | 35.48K | 36.57K | 36.54K | 35.48K | 34.24K | 31.48K | 29.84K |
Add to Watchlist
Select watchlists to add or remove XBIO